Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Gains from Sales and Divestitures (2017 - 2025)

Historic Gains from Sales and Divestitures for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $1.3 million.

  • Neuronetics' Gains from Sales and Divestitures fell 462.3% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 462.3%. This contributed to the annual value of $1.5 million for FY2024, which is 1969.28% down from last year.
  • Latest data reveals that Neuronetics reported Gains from Sales and Divestitures of $1.3 million as of Q3 2025, which was down 462.3% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Gains from Sales and Divestitures registered a high of $1.8 million during Q4 2023, and its lowest value of $318000.0 during Q1 2022.
  • Over the past 5 years, Neuronetics' median Gains from Sales and Divestitures value was $967000.0 (recorded in 2025), while the average stood at $1.0 million.
  • As far as peak fluctuations go, Neuronetics' Gains from Sales and Divestitures skyrocketed by 90625.0% in 2021, and later tumbled by 3020.48% in 2022.
  • Quarter analysis of 5 years shows Neuronetics' Gains from Sales and Divestitures stood at $780000.0 in 2021, then fell by 9.62% to $705000.0 in 2022, then soared by 158.58% to $1.8 million in 2023, then dropped by 19.69% to $1.5 million in 2024, then dropped by 8.4% to $1.3 million in 2025.
  • Its Gains from Sales and Divestitures was $1.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $967000.0 in Q1 2025.